222 related articles for article (PubMed ID: 10657544)
21. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
Kiguchi S; Imamura T; Ichikawa K; Kojima M
Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685
[TBL] [Abstract][Full Text] [Related]
22. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546).
Liu G; Henry KJ; Szczepankiewicz BG; Winn M; Kozmina NS; Boyd SA; Wasicak J; von Geldern TW; Wu-Wong JR; Chiou WJ; Dixon DB; Nguyen B; Marsh KC; Opgenorth TJ
J Med Chem; 1998 Aug; 41(17):3261-75. PubMed ID: 9703472
[TBL] [Abstract][Full Text] [Related]
23. Antineuropathic effect of 7-hydroxy-3,4-dihydrocadalin in streptozotocin-induced diabetic rodents.
Rocha-González HI; Ramírez-Aguilar M; Granados-Soto V; Reyes-García JG; Torres-López JE; Huerta-Cruz JC; Navarrete A
BMC Complement Altern Med; 2014 Apr; 14():129. PubMed ID: 24708659
[TBL] [Abstract][Full Text] [Related]
24. Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
Tawa M; Fukumoto T; Ohkita M; Matsumura Y
Eur J Pharmacol; 2008 Sep; 591(1-3):182-8. PubMed ID: 18586023
[TBL] [Abstract][Full Text] [Related]
25. Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats.
Ulugol A; Karadag HC; Tamer M; Firat Z; Aslantas A; Dokmeci I
Neurosci Lett; 2002 Aug; 328(2):129-32. PubMed ID: 12133572
[TBL] [Abstract][Full Text] [Related]
26. Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans.
Honing MLH; Hijmering ML; Ballard DE; Yang YP; Padley RJ; Morrison PJ; Rabelink TJ
J Am Soc Nephrol; 2000 Aug; 11(8):1498-1504. PubMed ID: 10906163
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
Yadav SK; Nagori BP; Desai PK
J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
[TBL] [Abstract][Full Text] [Related]
28. Role of endothelin ET(A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment.
Pollock DM; Polakowski JS; Opgenorth TJ; Pollock JS
Eur J Pharmacol; 1998 Apr; 346(1):43-50. PubMed ID: 9617750
[TBL] [Abstract][Full Text] [Related]
29. Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats.
Karadag HC; Ulugol A; Tamer M; Ipci Y; Dokmeci I
Neurosci Lett; 2003 Mar; 339(1):88-90. PubMed ID: 12618307
[TBL] [Abstract][Full Text] [Related]
30. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
31. Role of hydrogen sulfide in the pain processing of non-diabetic and diabetic rats.
Velasco-Xolalpa ME; Barragán-Iglesias P; Roa-Coria JE; Godínez-Chaparro B; Flores-Murrieta FJ; Torres-López JE; Araiza-Saldaña CI; Navarrete A; Rocha-González HI
Neuroscience; 2013 Oct; 250():786-97. PubMed ID: 23830907
[TBL] [Abstract][Full Text] [Related]
32. Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.
Katz NK; Ryals JM; Wright DE
Neuroscience; 2015 Jan; 285():312-23. PubMed ID: 25451280
[TBL] [Abstract][Full Text] [Related]
33. Type A, but not type B, endothelin receptor antagonists significantly decrease portal pressure in portal hypertensive rats.
De Gottardi A; Shaw S; Sägesser H; Reichen J
J Hepatol; 2000 Nov; 33(5):733-7. PubMed ID: 11097480
[TBL] [Abstract][Full Text] [Related]
34. Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain.
Chen SR; Khan GM; Pan HL
Anesthesiology; 2001 Oct; 95(4):1007-12. PubMed ID: 11605898
[TBL] [Abstract][Full Text] [Related]
35. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.
Bianciotti LG; de Bold AJ
Cardiovasc Res; 2001 Mar; 49(4):808-16. PubMed ID: 11230980
[TBL] [Abstract][Full Text] [Related]
36. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure.
Mulder P; Boujedaini H; Richard V; Derumeaux G; Henry JP; Renet S; Wessale J; Opgenorth T; Thuillez C
Circulation; 2000 Aug; 102(5):491-3. PubMed ID: 10920058
[TBL] [Abstract][Full Text] [Related]
37. Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats.
Miyauchi Y; Jesmin S; Sakai S; Kamiyama J; Shimojo N; Rahman A; Islam M; Zaedi S; Maeda S; Maruyama H; Mizutani T; Homma S; Aonuma K; Miyauchi T
Life Sci; 2014 Aug; 111(1-2):6-11. PubMed ID: 24953608
[TBL] [Abstract][Full Text] [Related]
38. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.
Suga S; Yasui N; Yoshihara F; Horio T; Kawano Y; Kangawa K; Johnson RJ
J Am Soc Nephrol; 2003 Feb; 14(2):397-406. PubMed ID: 12538740
[TBL] [Abstract][Full Text] [Related]
39. Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level.
Opgenorth TJ; Wessale JL; Dixon DB; Adler AL; Calzadilla SV; Padley RJ; Wu-Wong JR
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S292-6. PubMed ID: 11078402
[TBL] [Abstract][Full Text] [Related]
40. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]